Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest Content
Archive
For authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest Content
Archive
For authors
About
Podcasts
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 7, Issue 1
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Psoriatic arthritis
Original research
Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
Online download statistics by month:
Online download statistics by month: January 2021 to July 2022
Abstract
Full
Pdf
Jan 2021
4559
4543
113
Feb 2021
37601
37591
113
Mar 2021
254
239
37
Apr 2021
91
87
40
May 2021
70
67
25
Jun 2021
62
61
26
Jul 2021
62
58
20
Aug 2021
64
57
24
Sep 2021
56
50
23
Oct 2021
76
72
229
Nov 2021
55
49
54
Dec 2021
44
41
22
Jan 2022
36
37
28
Feb 2022
47
44
40
Mar 2022
83
76
35
Apr 2022
66
59
28
May 2022
85
81
26
Jun 2022
110
107
46
Jul 2022
82
78
27
Total
43503
43397
956
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF